Domo has a long history of technical expertise in the development, manufacture and marketing of protein hydrolysates, including specialty hydrolysates for reduced-allergenicity infant formula. The company has state-of-the-art research and development and applications labs, as well as exemplary pilot plant and manufacturing facilities. Domo pioneers the development of non-animal hydrolysates and plant-based peptones for use in biopharmaceutical and microbiological culture media applications. The company's products are sold to the infant nutrition, biopharmaceutical, microbiological, sports nutrition and medical nutrition markets. Domo is a leader in product quality, consistency and innovation; a specialist protein hydrolysate supplier with over 30 years of experience in protein hydrolysate production.
| Website | http://www.domo.nl |
| Revenue | $10.6 million |
| Employees | View employees |
| Address | Stationsplein 4, Amersfoort, Utrecht, NL |
| Phone | +31 33 713 2364 |
| Industry | Food & Beverages, Food, Beverages & Tobacco, Manufacturing |
| Competitors | Microsoft, IBM, Google, Salesforce, SAP, Tableau, Qlik, BankOne, Sisense, Looker +43 more (view full list) |
| SIC | SIC Code 20 Companies |
Looking for a particular Domo employee's phone or email?
Domo Questions
The Domo annual revenue was $10.6 million in 2026.
Domo is based in Amersfoort, Utrecht.
The SIC codes for Domo are [20].
